Research Ethics Boards: Reply from Trudo Lemmens and Carl Elliott
نویسندگان
چکیده
Joal Hill I read with interest the debate about for-profi t versus non-profi t institutional review boards (IRBs) [1], but was disappointed that no one addressed the ability (or inability) of for-profi t IRBs to review studies with the local context of research subjects in mind and then monitor what actually occurs during the consent process throughout the research trial. To my mind the “bigness” of for-profi t IRBs may be more of an impediment in protecting research subjects than their inherent confl ict of interest. Our IRB has reviewed consent forms approved by central/for-profi t IRBs that contained obvious errors such as schemas that did not match protocol narrative and use of eight point font in a study of geriatric subjects. Even when the initial review is outstanding, it seems a practical impossibility for a single IRB to provide meaningful monitoring of the actual consent process and implementation of the protocol at sites throughout the country. The greater “effi ciency” of for-profi t IRBs is only a meaningful benefi t if increased speed can be shown not to occur at the expense of careful review of consent forms, real understanding of the local research context, and a commitment to audit the informed consent process throughout the study for the protection of research subjects, including ongoing education and advice for researchers and their teams. This is not to say that all local IRBs perform this function as they should, but it does seem almost impossible for one IRB to perform local review and oversight for research sites around the nation in a way that really makes a difference for the men, women, and children who give of their time and their bodies so that society can benefi t.
منابع مشابه
Correction: Should Society Allow Research Ethics Boards to Be Run As For-Profit Enterprises?
BACKGROUND TO THE DEBATE An important mechanism for protecting human research participants is the prior approval of a clinical study by a research ethics board, known in the United States as an institutional review board (IRB). Traditionally, IRBs have been run by volunteer committees of scientists and clinicians working in the academic medical centers where the studies they review are being ca...
متن کاملStructuring the review of human genetics protocols, part III: gene therapy studies.
s understanding of the Astructure and functions of genes expands, so does the ability to manipulate them in new forms of treatment for inherited and acquired diseases. Gene therapy has been a topic of both scientific and ethical commentary for several decades. Actual experience in clinical trials is relatively recent, dating from the late 1980s. Since the first trial of gene transfer in humans ...
متن کاملGovernance of conflicts of interest in postmarketing surveillance research and the Canadian Drug Safety and Effectiveness Network
Lorraine E Ferris, PhD, LLM, is a professor at the Dalla Lana School of Public Health, University of Toronto, a senior scientist at the Clinical Epidemiology Unit, Sunnybrook Health Sciences Centre, and a senior scientist at the Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada. Trudo Lemmens, LicJur, LLM, DCL, is an associate professor at the Faculties of Law and Medicine, U...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- PLoS Medicine
دوره 3 شماره
صفحات -
تاریخ انتشار 2006